Honglian Yu

1.8k total citations
41 papers, 1.5k citations indexed

About

Honglian Yu is a scholar working on Molecular Biology, Biomedical Engineering and Analytical Chemistry. According to data from OpenAlex, Honglian Yu has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Biomedical Engineering and 8 papers in Analytical Chemistry. Recurrent topics in Honglian Yu's work include Analytical chemistry methods development (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Chromosomal and Genetic Variations (6 papers). Honglian Yu is often cited by papers focused on Analytical chemistry methods development (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Chromosomal and Genetic Variations (6 papers). Honglian Yu collaborates with scholars based in China, United States and Brazil. Honglian Yu's co-authors include Jared L. Anderson, Tien D. Ho, Fan Zhu, Kevin D. Clark, Josias Merib, Omprakash Nacham, William T. S. Cole, Donald R. Ronning, Tianhao Li and Yuejun Kang and has published in prestigious journals such as Biomaterials, Chemistry of Materials and Analytical Chemistry.

In The Last Decade

Honglian Yu

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honglian Yu China 23 404 397 380 221 220 41 1.5k
Xiaowen Wang China 25 483 1.2× 244 0.6× 265 0.7× 211 1.0× 106 0.5× 105 1.7k
Xueqin Ding China 28 468 1.2× 330 0.8× 246 0.6× 65 0.3× 770 3.5× 82 2.3k
Mingli Ye China 17 352 0.9× 243 0.6× 293 0.8× 158 0.7× 27 0.1× 59 1.4k
Giorgio Marrubini Italy 25 630 1.6× 277 0.7× 320 0.8× 132 0.6× 15 0.1× 81 1.8k
João Costa‐Rodrigues Portugal 22 600 1.5× 58 0.1× 268 0.7× 69 0.3× 144 0.7× 49 1.4k
Chun Wang China 22 518 1.3× 83 0.2× 108 0.3× 73 0.3× 94 0.4× 77 1.8k
Rui Ni China 15 191 0.5× 98 0.2× 175 0.5× 70 0.3× 89 0.4× 26 1.3k
B LI China 8 198 0.5× 74 0.2× 447 1.2× 60 0.3× 155 0.7× 8 2.1k
Xiaodong Hou China 26 520 1.3× 63 0.2× 453 1.2× 153 0.7× 19 0.1× 105 2.0k
Wenli Gao China 27 961 2.4× 54 0.1× 339 0.9× 394 1.8× 132 0.6× 92 2.5k

Countries citing papers authored by Honglian Yu

Since Specialization
Citations

This map shows the geographic impact of Honglian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglian Yu more than expected).

Fields of papers citing papers by Honglian Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglian Yu. The network helps show where Honglian Yu may publish in the future.

Co-authorship network of co-authors of Honglian Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Honglian Yu. A scholar is included among the top collaborators of Honglian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglian Yu. Honglian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shixue, et al.. (2025). The molecular pathogenesis of SOX2 in prostate cancer. Discover Oncology. 16(1). 215–215.
2.
Yu, Honglian, et al.. (2024). Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review). Oncology Reports. 51(3). 8 indexed citations
3.
Shi, Yongyong, et al.. (2023). Molecular mechanisms of syncytin-1 in tumors and placental development related diseases. Discover Oncology. 14(1). 104–104. 8 indexed citations
4.
Gao, Yankun, Ying Shi, Xiang‐Ling Li, et al.. (2023). The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?. Technology in Cancer Research & Treatment. 22. 2223917621–2223917621. 4 indexed citations
5.
Li, Bei, et al.. (2023). Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer. Discover Oncology. 14(1). 196–196. 8 indexed citations
6.
He, Mengting, Xiaoqin Wang, Honglian Yu, et al.. (2023). Nitrogen vacancy-rich carbon nitride anchored with iron atoms for efficient redox dyshomeostasis under ultrasound actuation. Biomaterials. 305. 122446–122446. 3 indexed citations
7.
Yu, Honglian, Mengting He, Yuhan Liu, et al.. (2022). A robust Au@Cu2-xS nanoreactor assembled by silk fibroin for enhanced intratumoral glucose depletion and redox dyshomeostasis. Biomaterials. 293. 121970–121970. 25 indexed citations
8.
Gao, Yankun, et al.. (2022). The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers. Frontiers in Oncology. 12. 948110–948110. 3 indexed citations
9.
Li, Siqi, et al.. (2022). The Biocompatibility of Multi-Source Stem Cells and Gelatin-Carboxymethyl Chitosan-Sodium Alginate Hybrid Biomaterials. Tissue Engineering and Regenerative Medicine. 19(3). 491–503. 17 indexed citations
10.
Chen, Ye, Qingsheng Kong, Dandan Li, et al.. (2019). Ureter tissue engineering with vessel extracellular matrix and differentiated urine-derived stem cells. Acta Biomaterialia. 88. 266–279. 27 indexed citations
11.
Li, Hongge, Yingyu Mao, Honglian Yu, et al.. (2019). Lens differentiation is controlled by the balance between PDGF and FGF signaling. PLoS Biology. 17(2). e3000133–e3000133. 27 indexed citations
12.
Yu, Honglian, Josias Merib, & Jared L. Anderson. (2016). Crosslinked polymeric ionic liquids as solid-phase microextraction sorbent coatings for high performance liquid chromatography. Journal of Chromatography A. 1438. 10–21. 53 indexed citations
13.
Yu, Honglian, et al.. (2016). Differentiate into urothelium and smooth muscle cells from adipose tissue-derived stem cells for ureter reconstruction in a rabbit model.. PubMed. 8(9). 3757–3768. 22 indexed citations
14.
Yu, Honglian, et al.. (2016). Antioxidative mechanism of Lycium barbarum polysaccharides promotes repair and regeneration following cavernous nerve injury. Neural Regeneration Research. 11(8). 1312–1312. 30 indexed citations
15.
Yu, Honglian, Kevin D. Clark, & Jared L. Anderson. (2015). Rapid and sensitive analysis of microcystins using ionic liquid-based in situ dispersive liquid–liquid microextraction. Journal of Chromatography A. 1406. 10–18. 45 indexed citations
16.
Qiu, Zhenpeng, Benhong Zhou, Long Jin, et al.. (2013). In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells. Food and Chemical Toxicology. 59. 428–437. 126 indexed citations
17.
Yu, Honglian, et al.. (2013). The role of human endogenous retroviral long terminal repeat sequences in human cancer (Review). International Journal of Molecular Medicine. 32(4). 755–762. 36 indexed citations
18.
Liu, Chunlan, Yatang Chen, Shan Li, et al.. (2013). Activation of elements in HERV-W family by caffeine and aspirin. Virus Genes. 47(2). 219–227. 27 indexed citations
19.
Yu, Honglian, Tien D. Ho, & Jared L. Anderson. (2013). Ionic liquid and polymeric ionic liquid coatings in solid-phase microextraction. TrAC Trends in Analytical Chemistry. 45. 219–232. 120 indexed citations
20.
Yu, Honglian, et al.. (2012). Differentiation of adipose-derived stem cells promotes regeneration of smooth muscle for ureteral tissue engineering. Journal of Surgical Research. 178(1). 55–62. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaowen Wang Breakdown of academic impact, for papers by Xueqin Ding Breakdown of academic impact, for papers by Mingli Ye Breakdown of academic impact, for papers by Giorgio Marrubini Breakdown of academic impact, for papers by João Costa‐Rodrigues Breakdown of academic impact, for papers by Chun Wang Breakdown of academic impact, for papers by Rui Ni Breakdown of academic impact, for papers by B LI Breakdown of academic impact, for papers by Xiaodong Hou Breakdown of academic impact, for papers by Wenli Gao
Rankless by CCL
2026